Thierry Mathieu is the Founder and President of Starkage Therapeutics. Mathieu is a medical doctor, specialized in immunology, molecular genetics, mmics and complex systems, senescence, medically assisted reproduction (IAC, IAD, IVF, ICSI) and hospital hygiene.

A successful serial entrepreneur, he has created several start-ups in the bio-technology and innovation sector. Mathieu participated in the creation, administration, management and transfer of the Synlab Biology Group (formerly known as Labco).